Bridion

Operative Surgery, Neuromuscular blockade caused by vecuronium bromide

Treatment

20 Active Studies for Bridion

What is Bridion

Sugammadex

The Generic name of this drug

Treatment Summary

Sugammadex (also known as Bridion) is a medication used to reverse the effects of certain drugs that cause temporary paralysis during surgery. These drugs, rocuronium bromide and vecuronium bromide, are used to help with general anesthesia, ventilation, or tracheal intubation. Sugammadex helps to reverse the effects of these drugs faster and allow patients to recover sooner after surgery. It was approved by the FDA in 2015 and is marketed by Merck Sharp and Dohme.

Bridion

is the brand name

Bridion Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Bridion

Sugammadex

2015

3

Effectiveness

How Bridion works in the body

Sugammadex is a modified sugar molecule. It forms strong bonds with certain drugs used to stop nerves from working, like rocuronium. This causes the drug to move out of the nerve and into the bloodstream, quickly reversing its effects. Sugammadex then binds tightly to any remaining drug in the bloodstream, helping it leave the nerve and enter the bloodstream.

When to interrupt dosage

The suggested dose of Bridion is contingent upon the diagnosed condition. The amount likewise relies upon the mode of delivery as detailed in the accompanying table.

Condition

Dosage

Administration

Operative Surgery

, 100.0 mg/mL

, Intravenous, Solution - Intravenous, Solution, Injection, solution, Injection, solution - Intravenous

Neuromuscular blockade caused by vecuronium bromide

, 100.0 mg/mL

, Intravenous, Solution - Intravenous, Solution, Injection, solution, Injection, solution - Intravenous

Warnings

There are 20 known major drug interactions with Bridion.

Common Bridion Drug Interactions

Drug Name

Risk Level

Description

Chlormadinone

Moderate

The serum concentration of Chlormadinone can be decreased when it is combined with Sugammadex.

Cyproterone acetate

Moderate

The serum concentration of Cyproterone acetate can be decreased when it is combined with Sugammadex.

Demegestone

Moderate

The serum concentration of Demegestone can be decreased when it is combined with Sugammadex.

Desogestrel

Moderate

The serum concentration of Desogestrel can be decreased when it is combined with Sugammadex.

Dienogest

Moderate

The serum concentration of Dienogest can be decreased when it is combined with Sugammadex.

Bridion Toxicity & Overdose Risk

People with severely reduced kidney function (creatinine clearance below 30 mL/min) should not take this drug, as their bodies cannot properly clear it from their system and there is not enough evidence about its safety for this group.

Bridion Novel Uses: Which Conditions Have a Clinical Trial Featuring Bridion?

No current trials are being conducted to explore the potential of Bridion to abate Neuromuscular blockade caused by vecuronium bromide.

Condition

Clinical Trials

Trial Phases

Neuromuscular blockade caused by vecuronium bromide

0 Actively Recruiting

Operative Surgery

75 Actively Recruiting

Phase 3, Not Applicable, Phase 4, Phase 1, Phase 2, Early Phase 1

Patient Q&A Section about bridion

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Bridion used for?

"BRIDION is an injection that helps to negate the effects of certain neuromuscular blocking drugs, rocuronium bromide, and vecuronium bromide. These drugs are used during particular types of surgeries on adults."

Answered by AI

What is sugammadex used for?

"This medication, SUGAMMADEX, is used to reverse the effects of the muscle relaxants rocuronium and vecuronium. These medicines are given to patients during surgery."

Answered by AI

How long does it take for sugammadex to wear off?

"Relaxation might take up to 4 minutes to start, and the effects might only last for 15 minutes."

Answered by AI

What are the side effects of sugammadex?

"The most common adverse reactions to sugammadex are vomiting, dry mouth, tachycardia, dizziness, and hypotension. However, there have been reports of severe hypotension following the administration of sugammadex, with systolic blood pressure falling to 50 mmHg or below."

Answered by AI

Clinical Trials for Bridion

Image of Washington University / Barnes Jewish Hospital in St Louis, United States.

AI-Driven Clinical Decision Support for Surgery

18+
All Sexes
St Louis, MO

20 million patients have surgery in the United States every year, with approximately 1 million of those patients requiring life-saving blood transfusion. Presurgical preparation for transfusion is important to allow for safe and timely transfusion during surgery; however, excessive preparation is unfortunately common, costly, and contributes to blood waste. This study aims to evaluate an intelligent clinical decision support system that helps clinicians prepare blood for patients who are likely to need it, while avoiding excessive preparation for patients who don't, potentially improving patient safety while reducing blood waste and healthcare costs.

Recruiting
Has No Placebo

Washington University / Barnes Jewish Hospital

Image of UPMC Shadyside Hospital in Pittsburgh, United States.

Bright Green Light Therapy for Postoperative Pain

18+
All Sexes
Pittsburgh, PA

This is an unblinded, parallel group randomized controlled trial to evaluate bright green light as an adjunct therapy after surgery at UPMC Shadyside. The primary outcome measure will be pain intensity with secondary outcome measures including opioid requirements, sleep quality, mood, and overall post-operative recovery. Specific aims/hypotheses for this study are as follows: Aim 1: To assess bright green light therapy's potential as a complementary post-operative analgesic strategy in patients recovering from surgery Hypothesis 1: Participants exposed to bright green light, in comparison to dim white (ambient) light, will have improved postoperative pain scores and lower opioid use. Aim 2: To examine the impact of bright green light therapy on patient-centered measures of post-operative recovery that may be related to improved circadian function. Hypothesis 2: Participants exposed to bright green light, in comparison to dim white (ambient) light, will have improved quality of post-operative recovery, enhanced sleep, and reduced anxiety and depression.

Waitlist Available
Has No Placebo

UPMC Shadyside Hospital

Rebecca Kotcher, MD

Image of Walter Reed National Military Medical Center in Bethesda, United States.

Corticosteroid Injections for Osteoarthritis

18+
All Sexes
Bethesda, MD

The goal of this clinical trial is to find out which type of steroid medicine, when added to a standard pain-control injection during total knee replacement surgery, works best at reducing pain, limiting opioid use, and improving recovery in adults undergoing surgery for severe knee arthritis or injury. The main questions it aims to answer are: Does adding a steroid to the injection improve pain control and reduce opioid use after surgery? Is the newer extended-release steroid (Zilretta) more effective and safer-especially for patients with diabetes-than the traditional steroid (methylprednisolone)? Researchers will compare: Standard pain-control injection alone Standard injection plus methylprednisolone Standard injection plus Zilretta to see which option provides better pain relief, less opioid use, and improved knee function. (Patients with diabetes or prediabetes will only be in the standard injection or Zilretta groups so researchers can study whether Zilretta is safer for blood sugar control.) Participants will: Be randomly assigned to one of the study groups during their total knee replacement surgery Receive the assigned pain-control injection around the knee joint Be followed after surgery to measure: Pain levels Opioid pain medication use Knee movement (range of motion) Whether another procedure (such as manipulation under anesthesia) is needed if the knee becomes too stiff Patient-reported outcome surveys about pain and function

Phase 2 & 3
Waitlist Available

Walter Reed National Military Medical Center

John P Cody, MD

Have you considered Bridion clinical trials?

We made a collection of clinical trials featuring Bridion, we think they might fit your search criteria.
Go to Trials
Image of Nationwide Children's Hospital in Columbus, United States.

Surface Electromyography for Surgery

No minimum age - 21
All Sexes
Columbus, OH

The investigators are studying a type of technology that is already used called surface electromyography (EMG). This measures and records electrical activity using sensor stickers in a non-invasive way. The purpose of this study is to use a prototype/test surface EMG machine to measure how well regional anesthesia (nerve block) is working. This device is non-invasive and being used for research use as an unapproved medical device. The information may teach us how to give nerve blocks more safely and effectively. Study participation: Subjects having surgery will have the surface EMG sensor stickers placed on their arms or legs before surgery. These will stay on during surgery and for part of recovery. Study visits: The study will consist of 1 visit that starts in the pre-operative area, through the surgery, and for part of recovery time after surgery.

Waitlist Available
Has No Placebo

Nationwide Children's Hospital

Grant Heydinger, MD

Have you considered Bridion clinical trials?

We made a collection of clinical trials featuring Bridion, we think they might fit your search criteria.
Go to Trials
Image of CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus) in Québec, Canada.

Lidocaine + Dexmedetomidine for Surgery Outcomes

18+
All Sexes
Québec, Canada

Up to 40% of patients experience suboptimal recovery in the days following major surgery, limiting their return to functional independence. Few preventive interventions exist, but intravenous dexmedetomidine and lidocaine administered during general anesthesia represent simple strategies that may significantly impact recovery and other patient-centred outcomes after surgery. The goal of this pilot trial is to determine the feasibility of conducting a phase 3 pragmatic adaptive multicentre trial to evaluate the impact of dexmedetomidine and lidocaine administered during major non-cardiac surgery on patient-centred outcomes.

Recruiting
Has No Placebo

CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus)

Michael Verret, MD PhD FRCPC

Image of University Health Network in Toronto, Canada.

Sleep Prehabilitation for Surgery

18+
All Sexes
Toronto, Canada

The goal of this clinical trial is to learn if changing sleep behaviour can improve sleep health in patients undergoing prehabilitation before elective surgery. Prehabilitation is the use of exercise, nutrition, and psychological support before surgery to improve recovery from surgery. The main questions it aims to answer are: Does changing sleep behaviour improve sleep before surgery? Does changing sleep behaviour improve recovery after surgery? Researchers will compare participants who receive sleep support with participants who do not receive sleep support to see if it improves sleep health and recovery from surgery. Participants will be asked to attend 4 meetings with the research team to learn how they can improve their sleep. They will use questionnaires, a diary, and a wearable tracker to record their sleep.

Recruiting
Has No Placebo

University Health Network

Ian Randall, MD

Image of The Ottawa Hospital in Ottawa, Canada.

Blood Transfusion Strategies for Surgery

18+
All Sexes
Ottawa, Canada

The goal of this pilot clinical trial is to learn if it is achievable to conduct a large-scale clinical trial whereby, the investigators will compare two ways of deciding when to give a blood transfusion during surgery. Participants in this study are adults undergoing surgery with a risk of significant blood loss. The main question it aims to answer is: * Is a trial designed to definitively test and compare two different red blood cell transfusion strategies feasible? Participants will: * Receive blood transfusions during surgery based on a higher (less than 90 g/L) or a lower (less than 70 g/L) hemoglobin value. * Complete questionnaires at 30 and 90 days after surgery.

Recruiting
Has No Placebo

The Ottawa Hospital

Guillaume Martel, MD, MSc, FRCSC, FACS

Have you considered Bridion clinical trials?

We made a collection of clinical trials featuring Bridion, we think they might fit your search criteria.
Go to Trials